Shared-link access · Not indexed
CJC-1295 (no DAC) + Ipamorelin Dosing Calculator
A step-by-step calculator for reconstitution volumes, syringe draw, and protocol reference. Educational use only — all dosing decisions require a licensed medical provider.
Read full CJC-1295 (no DAC) + Ipamorelin profile →1
Peptide2
Vial Setup3
Regimen4
CardCJC-1295 (no DAC) + Ipamorelin
Also known as: CJC-1295/Ipamorelin, CJC + Ipa, Mod GRF 1-29 + Ipamorelin, GHRH + GHRP blend
Community consensus — Protocol evidence level
Blend of CJC-1295 without DAC (a GHRH analog / Mod GRF 1-29) and Ipamorelin (a selective GHRP). Typical per-injection dose ~0.2 mg total = ~100 mcg CJC-1295 (no DAC) + ~100 mcg Ipamorelin. There are NO combination-specific human trials for this blend; all evidence cited is for the individual components studied separately. Dosing reflects community/practitioner saturation-dose convention, not clinical guidance.
Last reviewed: 2026-06-12
Contraindications — Do not use if:
- •Active or prior malignancy (GH/IGF-1 axis stimulation is theoretically mitogenic)
- •Uncontrolled diabetes or significant insulin resistance
- •Active proliferative diabetic retinopathy
- •Pregnancy or breastfeeding
- •Pituitary or other active endocrine tumor